PY4 |
DPH |
Alameda Health System |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0 |
0 |
44.00% |
0 |
1780 |
0 |
1819 |
0 |
97.90% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Alameda Health System |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
444 |
0 |
1022 |
0 |
43.40% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
374 |
0 |
994 |
0 |
37.60% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
2149 |
0 |
4629 |
0 |
46.40% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
7874 |
0 |
20041 |
0 |
39.30% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
5250 |
0 |
11831 |
0 |
44.40% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
266 |
0 |
594 |
0 |
44.80% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
1039 |
0 |
1552 |
0 |
67.00% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
6463 |
0 |
10927 |
0 |
59.20% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
517 |
0 |
1185 |
0 |
43.60% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
13875 |
0 |
20266 |
0 |
68.50% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
197 |
0 |
546 |
0 |
36.10% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
359 |
0 |
594 |
0 |
60.40% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
16228 |
0 |
23441 |
0 |
69.20% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
15735 |
0 |
26733 |
0 |
58.90% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
24623 |
0 |
24878 |
0 |
99.00% |
0 |
N/A |
None |
PY4 |
DPH |
Alameda Health System |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
3522 |
0 |
4356 |
0 |
80.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
23780 |
0 |
24878 |
0 |
95.60% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
5182 |
0 |
5679 |
0 |
91.30% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
4398 |
0 |
5679 |
0 |
77.40% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
4378 |
0 |
5679 |
0 |
77.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
371 |
0 |
603 |
0 |
61.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
19 |
0 |
32 |
0 |
59.40% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
21 |
0 |
611 |
0 |
3.40% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
156 |
0 |
260 |
0 |
60.00% |
0 |
1 |
YesS |
PY4 |
DPH |
Alameda Health System |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
45 |
0 |
260 |
0 |
17.30% |
0 |
1 |
YesS |
PY4 |
DPH |
Alameda Health System |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
76 |
0 |
260 |
0 |
29.20% |
0 |
1 |
YesS |
PY4 |
DPH |
Alameda Health System |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
PY4 |
DPH |
Alameda Health System |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
PY4 |
DPH |
Alameda Health System |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
PY4 |
DPH |
Alameda Health System |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-BH3 |
Q-FUA |
? 30 Days |
Reported |
0.00% |
0 |
10.80% |
0 |
35 |
0 |
260 |
0 |
13.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-BH3 |
Q-FUA |
? 7 Days |
Reported |
0.00% |
0 |
7.10% |
0 |
28 |
0 |
260 |
0 |
10.80% |
0 |
1 |
NoS |
PY4 |
DPH |
Alameda Health System |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
None |
1 |
623 |
0 |
None |
1 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
2709 |
0 |
4881 |
0 |
55.50% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
190 |
0 |
210 |
0 |
90.50% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
439 |
0 |
465 |
0 |
94.40% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
245 |
0 |
258 |
0 |
95.00% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
1402 |
0 |
3652 |
0 |
38.40% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
1933 |
0 |
3652 |
0 |
52.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
414 |
0 |
498 |
0 |
83.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
347 |
0 |
445 |
0 |
78.00% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
402 |
0 |
410 |
0 |
98.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
133 |
0 |
141 |
0 |
94.30% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
54 |
0 |
391 |
0 |
13.80% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
356 |
0 |
513 |
0 |
69.40% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
434 |
0 |
579 |
0 |
75.00% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
462 |
0 |
579 |
0 |
79.80% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
1258 |
0 |
7651 |
0 |
16.40% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
172 |
0 |
177 |
0 |
97.20% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
1920 |
0 |
2051 |
0 |
93.60% |
0 |
1 |
No |
PY4 |
DPH |
Alameda Health System |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
833 |
0 |
1458 |
0 |
57.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Alameda Health System |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Alameda Health System |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
21 |
0 |
34.209 |
0 |
0.614 |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
9.92 |
0 |
10.008 |
0 |
0.991 |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
112 |
0 |
380 |
0 |
29.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
522 |
0 |
1868 |
0 |
27.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-IHE2 |
Q-IHE2 |
? Controlling High Blood Pressure (CBP) - -Hispanic/Latino |
Reported |
0.00% |
0 |
50.60% |
0 |
80 |
0 |
180 |
0 |
44.40% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
1465 |
0 |
2926 |
0 |
50.10% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
111 |
0 |
408 |
0 |
27.20% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
3310 |
0 |
6037 |
0 |
54.80% |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
117 |
0 |
490 |
0 |
23.90% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
377 |
0 |
611 |
0 |
61.70% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
147 |
0 |
489 |
0 |
30.10% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
None |
1 |
1632 |
0 |
None |
1 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
2016 |
0 |
15293 |
0 |
13.20% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
110 |
0 |
309 |
0 |
35.60% |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
43 |
0 |
867 |
0 |
5.00% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
3895 |
0 |
4514 |
0 |
86.30% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
531 |
0 |
1063 |
0 |
50.00% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
244 |
0 |
373 |
0 |
65.40% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
34 |
0 |
219 |
0 |
15.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
55 |
0 |
1121 |
0 |
4.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
542 |
0 |
1074 |
0 |
50.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
542 |
0 |
1074 |
0 |
50.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
542 |
0 |
1074 |
0 |
50.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
None |
1 |
None |
1 |
N/A |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
24 |
0 |
952 |
0 |
2.50% |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
135 |
0 |
323 |
0 |
41.80% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
51 |
0 |
235 |
0 |
21.70% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
85 |
0 |
235 |
0 |
36.20% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
738 |
0 |
990 |
0 |
74.60% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
3176 |
0 |
5918 |
0 |
53.70% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
826 |
0 |
2929 |
0 |
28.20% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
1233 |
0 |
2929 |
0 |
42.10% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
11 |
0 |
52 |
0 |
21.20% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
Reported |
0.00% |
0 |
63.60% |
0 |
136 |
0 |
272 |
0 |
50.00% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
Reported |
0.00% |
0 |
78.70% |
0 |
98 |
0 |
272 |
0 |
36.00% |
0 |
1 |
NoS |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
347 |
0 |
358 |
0 |
96.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
104 |
0 |
140 |
0 |
74.30% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
116 |
0 |
764 |
0 |
15.20% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
96 |
0 |
584 |
0 |
16.40% |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
965 |
0 |
5639 |
0 |
17.10% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
406 |
0 |
529 |
0 |
76.80% |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
124 |
0 |
185 |
0 |
67.00% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
148 |
0 |
185 |
0 |
80.00% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
233 |
0 |
271 |
0 |
86.00% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
73 |
0 |
108 |
0 |
67.60% |
0 |
1 |
No |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
2.54 |
0 |
3.2355 |
0 |
0.7851 |
0 |
1 |
Yes |
PY4 |
DPH |
Arrowhead Regional Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
19 |
0 |
45.488 |
0 |
0.418 |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
2532 |
0 |
2553 |
0 |
99.20% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
61 |
0 |
81.738 |
0 |
0.746 |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
284 |
0 |
972 |
0 |
29.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
687 |
0 |
2244 |
0 |
30.60% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-IHE2 |
Q-IHE2 |
? Child and Adolescent Well Care Visits - -Black/African American |
Reported |
0.00% |
0 |
39.40% |
0 |
1708 |
0 |
3430 |
0 |
49.80% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
5471 |
0 |
8447 |
0 |
64.80% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
15378 |
0 |
24559 |
0 |
62.60% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
15876 |
0 |
28186 |
0 |
56.30% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
635 |
0 |
1452 |
0 |
43.70% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
2011 |
0 |
3014 |
0 |
66.70% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
12338 |
0 |
22028 |
0 |
56.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
2302 |
0 |
3332 |
0 |
69.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
28807 |
0 |
35088 |
0 |
82.10% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
713 |
0 |
1475 |
0 |
48.30% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
21966 |
0 |
40802 |
0 |
53.80% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
29660 |
0 |
34459 |
0 |
86.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
28512 |
0 |
38219 |
0 |
74.60% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
43416 |
0 |
45166 |
0 |
96.10% |
0 |
N/A |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
3469 |
0 |
7188 |
0 |
48.30% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
39700 |
0 |
45166 |
0 |
87.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
14486 |
0 |
15825 |
0 |
91.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
13489 |
0 |
15825 |
0 |
85.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
13495 |
0 |
15825 |
0 |
85.30% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
892 |
0 |
1296 |
0 |
68.80% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
485 |
0 |
622 |
0 |
78.00% |
0 |
1 |
NoS |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
74 |
0 |
1439 |
0 |
5.10% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
18 |
0 |
1121 |
0 |
1.60% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
4624 |
0 |
7111 |
0 |
65.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
702 |
0 |
802 |
0 |
87.50% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
1652 |
0 |
1774 |
0 |
93.10% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
406 |
0 |
434 |
0 |
93.60% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
5442 |
0 |
6821 |
0 |
79.80% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
1730 |
0 |
6335 |
0 |
27.30% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
4120 |
0 |
6335 |
0 |
65.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
5651 |
0 |
6335 |
0 |
89.20% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
388 |
0 |
474 |
0 |
81.90% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
644 |
0 |
1126 |
0 |
57.20% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
677 |
0 |
709 |
0 |
95.50% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
79 |
0 |
113 |
0 |
69.90% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
790 |
0 |
925 |
0 |
85.40% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
81 |
0 |
468 |
0 |
17.30% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
1136 |
0 |
1483 |
0 |
76.60% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
799 |
0 |
886 |
0 |
90.20% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
813 |
0 |
886 |
0 |
91.80% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
4445 |
0 |
10345 |
0 |
43.00% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
804 |
0 |
816 |
0 |
98.50% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
187 |
0 |
190 |
0 |
98.40% |
0 |
1 |
No |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Contra Costa Regional Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
984 |
0 |
1153 |
0 |
85.30% |
0 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Kern Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
91 |
0 |
207 |
0 |
44.00% |
0 |
1 |
YesS |
PY4 |
DPH |
Kern Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
634 |
0 |
1500 |
0 |
42.30% |
0 |
1 |
YesS |
PY4 |
DPH |
Kern Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
963 |
0 |
2147 |
0 |
44.90% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
3355 |
0 |
10285 |
0 |
32.60% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
4220 |
0 |
12567 |
0 |
33.60% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
191 |
0 |
821 |
0 |
23.30% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
565 |
0 |
1524 |
0 |
37.10% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
2260 |
0 |
5006 |
0 |
45.20% |
0 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
70 |
0 |
2239 |
0 |
3.10% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
5429 |
0 |
12941 |
0 |
42.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
152 |
0 |
1000 |
0 |
15.20% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
309 |
0 |
823 |
0 |
37.60% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
6847 |
0 |
15659 |
0 |
43.70% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
5141 |
0 |
12378 |
0 |
41.50% |
0 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
6159 |
0 |
15093 |
0 |
40.80% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
13387 |
0 |
13631 |
0 |
98.20% |
0 |
N/A |
None |
PY4 |
DPH |
Kern Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
635 |
0 |
2185 |
0 |
29.10% |
0 |
1 |
YesS |
PY4 |
DPH |
Kern Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
11837 |
0 |
13631 |
0 |
86.80% |
0 |
1 |
YesS |
PY4 |
DPH |
Kern Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
4387 |
0 |
4513 |
0 |
97.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Kern Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
686 |
0 |
4513 |
0 |
15.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Kern Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
563 |
0 |
4513 |
0 |
12.50% |
0 |
1 |
Nos |
PY4 |
DPH |
Kern Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
300 |
0 |
892 |
0 |
33.60% |
0 |
1 |
NoS |
PY4 |
DPH |
Kern Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
227 |
0 |
569 |
0 |
39.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Kern Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
13 |
0 |
473 |
0 |
2.80% |
0 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
0 |
0 |
377 |
0 |
0.00% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
1550 |
0 |
2748 |
0 |
56.40% |
0 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
179 |
0 |
206 |
0 |
86.90% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
344 |
0 |
367 |
0 |
93.70% |
0 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
61 |
0 |
62 |
0 |
98.40% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
1752 |
0 |
2373 |
0 |
73.80% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
1065 |
0 |
2384 |
0 |
44.70% |
0 |
1 |
Yes |
PY4 |
DPH |
Kern Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
696 |
0 |
2384 |
0 |
29.20% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
1952 |
0 |
2384 |
0 |
81.90% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
63 |
0 |
97 |
0 |
65.00% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
130 |
0 |
275 |
0 |
47.30% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
218 |
0 |
249 |
0 |
87.60% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
117 |
0 |
172 |
0 |
68.00% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
130 |
0 |
538 |
0 |
24.20% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
1110 |
0 |
1672 |
0 |
66.40% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
227 |
0 |
764 |
0 |
29.70% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
232 |
0 |
764 |
0 |
30.40% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
1277 |
0 |
1465 |
0 |
87.20% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
30 |
0 |
30 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
982 |
0 |
1085 |
0 |
90.50% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
544 |
0 |
606 |
0 |
89.80% |
0 |
1 |
No |
PY4 |
DPH |
Kern Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Kern Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
7485 |
0 |
8653 |
0 |
86.50% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
995 |
0 |
2638 |
0 |
37.70% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
4345 |
0 |
11213 |
0 |
38.80% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
9311 |
0 |
17255 |
0 |
54.00% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
26743 |
0 |
64661 |
0 |
41.40% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
14087 |
0 |
36739 |
0 |
38.30% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
150 |
0 |
323 |
0 |
46.40% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
3190 |
0 |
5337 |
0 |
59.80% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
34061 |
0 |
58074 |
0 |
58.70% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
223 |
0 |
411 |
0 |
54.30% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
36496 |
0 |
66493 |
0 |
54.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
126 |
0 |
323 |
0 |
39.00% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
1056 |
0 |
1836 |
0 |
57.50% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
49246 |
0 |
84832 |
0 |
58.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
80855 |
0 |
100901 |
0 |
80.10% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
121425 |
0 |
135294 |
0 |
89.80% |
0 |
1 |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
7889 |
0 |
13835 |
0 |
57.00% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
115479 |
0 |
135293 |
0 |
85.40% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
13479 |
0 |
16427 |
0 |
82.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
12031 |
0 |
16427 |
0 |
73.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
11857 |
0 |
16427 |
0 |
72.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
1090 |
0 |
1741 |
0 |
62.60% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
435 |
0 |
666 |
0 |
65.30% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
150 |
0 |
2181 |
0 |
6.90% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
496 |
0 |
1013 |
0 |
49.00% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
143 |
0 |
1013 |
0 |
14.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
206 |
0 |
1013 |
0 |
20.30% |
0 |
1 |
NoS |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
22 |
0 |
59 |
0 |
37.30% |
0 |
1 |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
None |
1 |
59 |
0 |
None |
1 |
1 |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
59 |
0 |
None |
1 |
1 |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
9566 |
0 |
17731 |
0 |
54.00% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
2055 |
0 |
2352 |
0 |
87.40% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
3945 |
0 |
4723 |
0 |
83.50% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
1826 |
0 |
2135 |
0 |
85.50% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
14351 |
0 |
18675 |
0 |
76.90% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
6590 |
0 |
17248 |
0 |
38.20% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
9260 |
0 |
17248 |
0 |
53.70% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
2866 |
0 |
3436 |
0 |
83.40% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
975 |
0 |
1515 |
0 |
64.40% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
522 |
0 |
527 |
0 |
99.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
52 |
0 |
56 |
0 |
92.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
1073 |
0 |
1263 |
0 |
85.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Los Angeles County Health System |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
1103 |
0 |
1845 |
0 |
59.80% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
1196 |
0 |
1590 |
0 |
75.20% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
1343 |
0 |
1590 |
0 |
84.50% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
24747 |
0 |
26473 |
0 |
93.50% |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
218 |
0 |
218 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
354 |
0 |
380 |
0 |
93.20% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
298 |
0 |
323 |
0 |
92.30% |
0 |
1 |
No |
PY4 |
DPH |
Los Angeles County Health System |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
16 |
0 |
38.275 |
0 |
0.418 |
0 |
1 |
Yes |
PY4 |
DPH |
Los Angeles County Health System |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
112 |
0 |
191.927 |
0 |
0.584 |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
487 |
0 |
1278 |
0 |
38.10% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
49 |
0 |
147 |
0 |
0.333 |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
14 |
0 |
41 |
0 |
34.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
396 |
0 |
1060 |
0 |
37.40% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
802 |
0 |
1588 |
0 |
50.50% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
4072 |
0 |
7414 |
0 |
54.90% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
11516 |
0 |
23950 |
0 |
48.10% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
722 |
0 |
1328 |
0 |
54.40% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
180 |
0 |
345 |
0 |
52.20% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
3578 |
0 |
6169 |
0 |
58.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
22 |
0 |
2914 |
0 |
0.80% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
6244 |
0 |
11099 |
0 |
56.30% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
866 |
0 |
1442 |
0 |
60.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
1027 |
0 |
1335 |
0 |
76.90% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
14902 |
0 |
25689 |
0 |
58.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
14350 |
0 |
22089 |
0 |
65.00% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
12783 |
0 |
13312 |
0 |
96.00% |
0 |
1 |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
599 |
0 |
1022 |
0 |
58.60% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
12360 |
0 |
13312 |
0 |
92.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
728 |
0 |
1291 |
0 |
56.40% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
137 |
0 |
297 |
0 |
46.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
21 |
0 |
542 |
0 |
3.90% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
91 |
0 |
229 |
0 |
39.70% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
18 |
0 |
229 |
0 |
7.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
36 |
0 |
229 |
0 |
15.70% |
0 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
12 |
0 |
48 |
0 |
25.00% |
0 |
0 |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
None |
1 |
48 |
0 |
None |
1 |
0 |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
48 |
0 |
None |
1 |
0 |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-BH3 |
Q-FUA |
? 30 Days |
Reported |
0.00% |
0 |
10.80% |
0 |
None |
1 |
201 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-BH3 |
Q-FUA |
? 7 Days |
Reported |
0.00% |
0 |
7.10% |
0 |
None |
1 |
201 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
Natividad Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
16 |
0 |
278 |
0 |
5.80% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
1278 |
0 |
2080 |
0 |
61.40% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
131 |
0 |
166 |
0 |
78.90% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
224 |
0 |
286 |
0 |
78.30% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
40 |
0 |
47 |
0 |
85.10% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
996 |
0 |
1319 |
0 |
75.50% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
490 |
0 |
1395 |
0 |
35.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
800 |
0 |
1395 |
0 |
57.40% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
131 |
0 |
165 |
0 |
79.40% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
364 |
0 |
366 |
0 |
99.50% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
1118 |
0 |
1123 |
0 |
99.60% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
35 |
0 |
35 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
87 |
0 |
433 |
0 |
20.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
1857 |
0 |
8792 |
0 |
21.10% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
308 |
0 |
362 |
0 |
85.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
290 |
0 |
362 |
0 |
80.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Natividad Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Natividad Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
896 |
0 |
970 |
0 |
92.40% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
375 |
0 |
427 |
0 |
87.80% |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
1 |
0 |
5.672 |
0 |
0.1763 |
0 |
1 |
No |
PY4 |
DPH |
Natividad Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
8 |
0 |
20.742 |
0 |
0.386 |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
431 |
0 |
442 |
0 |
97.50% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Riverside University Health System |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
214 |
0 |
614 |
0 |
34.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Riverside University Health System |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
1204 |
0 |
3534 |
0 |
34.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Riverside University Health System |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
2935 |
0 |
5669 |
0 |
51.80% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
12221 |
0 |
27727 |
0 |
44.10% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
6294 |
0 |
18602 |
0 |
33.80% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
205 |
0 |
1164 |
0 |
17.60% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
2072 |
0 |
2966 |
0 |
69.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
9322 |
0 |
20328 |
0 |
45.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
801 |
0 |
2768 |
0 |
28.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
20236 |
0 |
27772 |
0 |
72.90% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
159 |
0 |
775 |
0 |
20.50% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
426 |
0 |
869 |
0 |
49.00% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
16139 |
0 |
32254 |
0 |
50.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
38054 |
0 |
56741 |
0 |
67.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
31202 |
0 |
34906 |
0 |
89.40% |
0 |
1 |
None |
PY4 |
DPH |
Riverside University Health System |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
3214 |
0 |
5158 |
0 |
62.30% |
0 |
1 |
YesS |
PY4 |
DPH |
Riverside University Health System |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
29814 |
0 |
34906 |
0 |
85.40% |
0 |
1 |
YesS |
PY4 |
DPH |
Riverside University Health System |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
300 |
0 |
608 |
0 |
49.30% |
0 |
1 |
NoS |
PY4 |
DPH |
Riverside University Health System |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
72 |
0 |
303 |
0 |
23.80% |
0 |
1 |
NoS |
PY4 |
DPH |
Riverside University Health System |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
130 |
0 |
2385 |
0 |
5.50% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
528 |
0 |
1170 |
0 |
45.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Riverside University Health System |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
134 |
0 |
1170 |
0 |
11.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Riverside University Health System |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
206 |
0 |
1170 |
0 |
17.60% |
0 |
1 |
NoS |
PY4 |
DPH |
Riverside University Health System |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
18 |
0 |
66 |
0 |
27.30% |
0 |
1 |
None |
PY4 |
DPH |
Riverside University Health System |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
None |
1 |
66 |
0 |
None |
1 |
1 |
None |
PY4 |
DPH |
Riverside University Health System |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
66 |
0 |
None |
1 |
1 |
None |
PY4 |
DPH |
Riverside University Health System |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
39 |
0 |
1526 |
0 |
2.60% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
3835 |
0 |
6286 |
0 |
61.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
260 |
0 |
283 |
0 |
91.90% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
949 |
0 |
1107 |
0 |
85.70% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
224 |
0 |
330 |
0 |
67.90% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
1961 |
0 |
5795 |
0 |
33.80% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
3445 |
0 |
5795 |
0 |
59.50% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
4991 |
0 |
5795 |
0 |
86.10% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
390 |
0 |
473 |
0 |
82.50% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
542 |
0 |
884 |
0 |
61.30% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
90 |
0 |
90 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
23 |
0 |
45 |
0 |
51.10% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
127 |
0 |
220 |
0 |
57.70% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
411 |
0 |
461 |
0 |
89.20% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
85 |
0 |
400 |
0 |
21.30% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
767 |
0 |
1115 |
0 |
68.80% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
1233 |
0 |
1710 |
0 |
72.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Riverside University Health System |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
1049 |
0 |
1710 |
0 |
61.40% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
237 |
0 |
237 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
315 |
0 |
320 |
0 |
98.40% |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Riverside University Health System |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
2 |
0 |
10.908 |
0 |
0.1834 |
0 |
1 |
No |
PY4 |
DPH |
Riverside University Health System |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
32 |
0 |
57.676 |
0 |
0.555 |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
2259 |
0 |
2287 |
0 |
98.80% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
230 |
0 |
739 |
0 |
31.10% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
369 |
0 |
1013 |
0 |
36.40% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-IHE2 |
Q-IHE2 |
? Controlling High Blood Pressure (CBP) - -Black/African American |
Reported |
0.00% |
0 |
50.60% |
0 |
658 |
0 |
1292 |
0 |
50.90% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
2392 |
0 |
4732 |
0 |
50.60% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
5213 |
0 |
10948 |
0 |
47.60% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
4422 |
0 |
9352 |
0 |
47.30% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
253 |
0 |
554 |
0 |
45.70% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
621 |
0 |
837 |
0 |
74.20% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
9112 |
0 |
15150 |
0 |
60.20% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
825 |
0 |
1456 |
0 |
56.70% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
12386 |
0 |
15359 |
0 |
80.60% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
288 |
0 |
492 |
0 |
58.50% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
432 |
0 |
535 |
0 |
80.80% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
16177 |
0 |
21573 |
0 |
75.00% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
13758 |
0 |
22202 |
0 |
62.00% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0 |
0 |
N/A |
0 |
32445 |
0 |
33257 |
0 |
97.60% |
0 |
N/A |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
5596 |
0 |
7346 |
0 |
76.20% |
0 |
1 |
YesS |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
30695 |
0 |
33257 |
0 |
92.30% |
0 |
1 |
YesS |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
428 |
0 |
488 |
0 |
87.70% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
135 |
0 |
193 |
0 |
70.00% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
51 |
0 |
583 |
0 |
8.80% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
168 |
0 |
556 |
0 |
30.20% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
18 |
0 |
556 |
0 |
3.20% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
32 |
0 |
556 |
0 |
5.80% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
12 |
0 |
55 |
0 |
21.80% |
0 |
N/A |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
0 |
0 |
55 |
0 |
0.00% |
0 |
N/A |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
55 |
0 |
None |
1 |
N/A |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
2702 |
0 |
4757 |
0 |
56.80% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
382 |
0 |
428 |
0 |
89.30% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
769 |
0 |
857 |
0 |
89.70% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
291 |
0 |
321 |
0 |
90.70% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
3082 |
0 |
4041 |
0 |
76.30% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
1005 |
0 |
3429 |
0 |
29.30% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
1917 |
0 |
3397 |
0 |
56.40% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
3079 |
0 |
3397 |
0 |
90.60% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
1777 |
0 |
2104 |
0 |
84.50% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
226 |
0 |
487 |
0 |
46.40% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
Reported |
0.00% |
0 |
63.60% |
0 |
65 |
0 |
104 |
0 |
62.50% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
Reported |
0.00% |
0 |
78.70% |
0 |
100 |
0 |
104 |
0 |
96.20% |
0 |
1 |
NoS |
PY4 |
DPH |
San Francisco General Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
350 |
0 |
356 |
0 |
98.30% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
35 |
0 |
35 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
58 |
0 |
290 |
0 |
20.00% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
2026 |
0 |
8376 |
0 |
24.20% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
605 |
0 |
730 |
0 |
82.90% |
0 |
1 |
Yes |
PY4 |
DPH |
San Francisco General Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
271 |
0 |
311 |
0 |
87.10% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
263 |
0 |
311 |
0 |
84.60% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
238 |
0 |
238 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
340 |
0 |
377 |
0 |
90.20% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
308 |
0 |
356 |
0 |
86.50% |
0 |
1 |
No |
PY4 |
DPH |
San Francisco General Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Francisco General Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
149 |
0 |
1061 |
0 |
0.14 |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
107 |
0 |
216 |
0 |
49.50% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
178 |
0 |
357 |
0 |
49.90% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
831 |
0 |
1974 |
0 |
42.10% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
3285 |
0 |
11431 |
0 |
28.70% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
4424 |
0 |
11464 |
0 |
38.60% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
68 |
0 |
299 |
0 |
22.70% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
224 |
0 |
418 |
0 |
53.60% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
2447 |
0 |
4687 |
0 |
52.20% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
267 |
0 |
411 |
0 |
65.00% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
3499 |
0 |
10523 |
0 |
33.30% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
69 |
0 |
179 |
0 |
38.60% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
3425 |
0 |
5933 |
0 |
57.70% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
3750 |
0 |
16766 |
0 |
22.40% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
108 |
0 |
351 |
0 |
30.80% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
8562 |
0 |
19279 |
0 |
44.40% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
21941 |
0 |
23795 |
0 |
92.20% |
0 |
1 |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
1730 |
0 |
3842 |
0 |
45.00% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
19868 |
0 |
23795 |
0 |
83.50% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
4081 |
0 |
4445 |
0 |
91.80% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
3295 |
0 |
4445 |
0 |
74.10% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
3316 |
0 |
4445 |
0 |
74.60% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
239 |
0 |
518 |
0 |
46.10% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
71 |
0 |
144 |
0 |
49.30% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
18 |
0 |
355 |
0 |
5.10% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
17 |
0 |
176 |
0 |
9.70% |
0 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
None |
1 |
176 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
None |
1 |
176 |
0 |
None |
1 |
1 |
NOS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
0 |
0 |
None |
1 |
None |
1 |
1 |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
0 |
0 |
None |
1 |
None |
1 |
1 |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
0 |
0 |
None |
1 |
None |
1 |
1 |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH3 |
Q-FUA |
? 30 Days |
Reported |
0.00% |
0 |
10.80% |
0 |
None |
1 |
77 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH3 |
Q-FUA |
? 7 Days |
Reported |
0.00% |
0 |
7.10% |
0 |
None |
1 |
77 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
San Joaquin General Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
843 |
0 |
2187 |
0 |
38.60% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
239 |
0 |
277 |
0 |
86.30% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
897 |
0 |
1139 |
0 |
78.80% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
764 |
0 |
1743 |
0 |
43.80% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
139 |
0 |
411 |
0 |
33.80% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
44 |
0 |
92 |
0 |
47.80% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
97 |
0 |
172 |
0 |
56.40% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
542 |
0 |
567 |
0 |
95.60% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
427 |
0 |
498 |
0 |
85.70% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
80 |
0 |
405 |
0 |
19.80% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
469 |
0 |
10261 |
0 |
4.60% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
821 |
0 |
1172 |
0 |
70.10% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
87 |
0 |
143 |
0 |
60.80% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
103 |
0 |
143 |
0 |
72.00% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
59 |
0 |
270 |
0 |
21.90% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
84 |
0 |
84 |
0 |
100.00% |
0 |
1 |
Yes |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
338 |
0 |
384 |
0 |
88.00% |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
19 |
0 |
11.29 |
0 |
1.6829 |
0 |
1 |
No |
PY4 |
DPH |
San Joaquin General Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
9 |
0 |
22.836 |
0 |
0.394 |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
175 |
0 |
321 |
0 |
54.50% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
31 |
0 |
92 |
0 |
33.70% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
289 |
0 |
861 |
0 |
33.60% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-IHE2 |
Q-IHE2 |
? Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 1 (informational only) -Black/African American |
Reported |
0.00% |
0 |
0.00% |
0 |
359 |
0 |
363 |
0 |
98.90% |
0 |
0 |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-IHE2 |
Q-IHE2 |
? Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 2 -Black/African American |
Reported |
0.00% |
0 |
6.70% |
0 |
73 |
0 |
120 |
0 |
60.80% |
0 |
1 |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-IHE2 |
Q-IHE2 |
? Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention - Rate 3 -Black/African American |
Reported |
0.00% |
0 |
75.40% |
0 |
312 |
0 |
363 |
0 |
86.00% |
0 |
1 |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
941 |
0 |
1321 |
0 |
71.20% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
2718 |
0 |
3928 |
0 |
69.20% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
7461 |
0 |
9631 |
0 |
77.50% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
301 |
0 |
429 |
0 |
70.20% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
952 |
0 |
1193 |
0 |
79.80% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
5101 |
0 |
8835 |
0 |
57.70% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
570 |
0 |
895 |
0 |
63.70% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
7416 |
0 |
10956 |
0 |
67.70% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
316 |
0 |
558 |
0 |
56.60% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
402 |
0 |
429 |
0 |
93.70% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
7242 |
0 |
19261 |
0 |
37.60% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
8618 |
0 |
13687 |
0 |
63.00% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
12681 |
0 |
22869 |
0 |
55.50% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
10732 |
0 |
10810 |
0 |
99.30% |
0 |
N/A |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
730 |
0 |
1565 |
0 |
46.70% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
9877 |
0 |
10810 |
0 |
91.40% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
6552 |
0 |
7326 |
0 |
89.40% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
6355 |
0 |
7326 |
0 |
86.80% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
1245 |
0 |
7326 |
0 |
17.00% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
375 |
0 |
439 |
0 |
85.40% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
102 |
0 |
164 |
0 |
62.20% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
25 |
0 |
244 |
0 |
10.30% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
150 |
0 |
539 |
0 |
27.80% |
0 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
39 |
0 |
539 |
0 |
7.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
59 |
0 |
539 |
0 |
11.00% |
0 |
1 |
Nos |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
22 |
0 |
125 |
0 |
17.60% |
0 |
N/A |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
None |
1 |
125 |
0 |
None |
1 |
N/A |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
125 |
0 |
None |
1 |
N/A |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
1583 |
0 |
3052 |
0 |
51.90% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
140 |
0 |
163 |
0 |
85.90% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
429 |
0 |
465 |
0 |
92.30% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
35 |
0 |
41 |
0 |
85.40% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
2471 |
0 |
3246 |
0 |
76.10% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
554 |
0 |
1939 |
0 |
28.60% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
1198 |
0 |
1939 |
0 |
61.80% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
279 |
0 |
364 |
0 |
76.70% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
54 |
0 |
63 |
0 |
85.70% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
Reported |
0.00% |
0 |
63.60% |
0 |
11 |
0 |
None |
4 |
None |
4 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
Reported |
0.00% |
0 |
78.70% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
San Mateo Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
279 |
0 |
279 |
0 |
100.00% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
105 |
0 |
127 |
0 |
82.70% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
247 |
0 |
262 |
0 |
94.30% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
261 |
0 |
276 |
0 |
94.60% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
236 |
0 |
268 |
0 |
88.10% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
None |
1 |
4933 |
0 |
None |
1 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
374 |
0 |
376 |
0 |
99.50% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
52 |
0 |
75 |
0 |
69.30% |
0 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
3810 |
0 |
3892 |
0 |
97.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
159 |
0 |
260.038 |
0 |
0.611 |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
151 |
0 |
405 |
0 |
37.30% |
0 |
1 |
YesS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
1228 |
0 |
2813 |
0 |
43.70% |
0 |
1 |
YesS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
3014 |
0 |
5407 |
0 |
55.70% |
0 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
8551 |
0 |
16890 |
0 |
50.60% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
15279 |
0 |
33679 |
0 |
45.40% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
1142 |
0 |
1926 |
0 |
59.30% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
1896 |
0 |
3129 |
0 |
60.60% |
0 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
9324 |
0 |
16156 |
0 |
57.70% |
0 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
3233 |
0 |
4424 |
0 |
73.10% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
19015 |
0 |
27605 |
0 |
68.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
635 |
0 |
2091 |
0 |
30.40% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
1541 |
0 |
2059 |
0 |
74.80% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
24229 |
0 |
49054 |
0 |
49.40% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
10672 |
0 |
27386 |
0 |
39.00% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
41089 |
0 |
42305 |
0 |
97.10% |
0 |
0 |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
2263 |
0 |
6455 |
0 |
35.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
36897 |
0 |
42305 |
0 |
87.20% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
15224 |
0 |
18347 |
0 |
83.00% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
12825 |
0 |
18347 |
0 |
69.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
12466 |
0 |
18347 |
0 |
68.00% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
1377 |
0 |
1984 |
0 |
69.40% |
0 |
1 |
YesS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
467 |
0 |
721 |
0 |
64.80% |
0 |
1 |
YesS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
87 |
0 |
911 |
0 |
9.60% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
146 |
0 |
609 |
0 |
24.00% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
35 |
0 |
609 |
0 |
5.80% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
54 |
0 |
609 |
0 |
8.90% |
0 |
1 |
NoS |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
0 |
0 |
None |
1 |
None |
1 |
0 |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
0 |
0 |
None |
1 |
None |
1 |
0 |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
0 |
0 |
None |
1 |
None |
1 |
0 |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
29 |
0 |
760 |
0 |
3.80% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
2786 |
0 |
5965 |
0 |
46.70% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
655 |
0 |
795 |
0 |
82.40% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
711 |
0 |
750 |
0 |
94.80% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
562 |
0 |
643 |
0 |
87.40% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
2376 |
0 |
6694 |
0 |
35.50% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
5618 |
0 |
6694 |
0 |
83.90% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
6008 |
0 |
6694 |
0 |
89.80% |
0 |
1 |
Yes |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
641 |
0 |
784 |
0 |
81.80% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
632 |
0 |
1174 |
0 |
53.80% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
118 |
0 |
118 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
2155 |
0 |
3063 |
0 |
70.40% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
587 |
0 |
771 |
0 |
76.10% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
633 |
0 |
771 |
0 |
82.10% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
4567 |
0 |
12158 |
0 |
37.60% |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
324 |
0 |
324 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
4539 |
0 |
4551 |
0 |
99.70% |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
1829 |
0 |
2480 |
0 |
73.80% |
0 |
1 |
Yes |
PY4 |
DPH |
San Mateo Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
35 |
0 |
18.731 |
0 |
1.8686 |
0 |
1 |
No |
PY4 |
DPH |
Santa Clara Valley Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
68 |
0 |
105.746 |
0 |
0.643 |
0 |
1 |
No |
PY4 |
DPH |
San Mateo Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
San Mateo Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
284 |
0 |
285 |
0 |
99.70% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
26 |
0 |
66 |
0 |
39.40% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
30 |
0 |
75 |
0 |
40.00% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
130 |
0 |
242 |
0 |
53.70% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
558 |
0 |
1108 |
0 |
50.40% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
458 |
0 |
1682 |
0 |
27.20% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
31 |
0 |
159 |
0 |
19.50% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
55 |
0 |
90 |
0 |
61.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
2165 |
0 |
4884 |
0 |
44.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
23 |
0 |
291 |
0 |
7.90% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
1246 |
0 |
1562 |
0 |
79.80% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
24 |
0 |
104 |
0 |
23.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
43 |
0 |
159 |
0 |
27.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
8948 |
0 |
22558 |
0 |
39.70% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
2641 |
0 |
9863 |
0 |
26.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
16084 |
0 |
17365 |
0 |
92.60% |
0 |
N/A |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
1018 |
0 |
2386 |
0 |
42.70% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
14447 |
0 |
17096 |
0 |
84.50% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
38 |
0 |
120 |
0 |
31.70% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
None |
1 |
36 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
None |
1 |
114 |
0 |
None |
1 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
22 |
0 |
38 |
0 |
57.90% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
None |
1 |
38 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
None |
1 |
38 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
0 |
0 |
None |
1 |
None |
1 |
N/A |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
None |
1 |
93 |
0 |
None |
1 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
108 |
0 |
172 |
0 |
62.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
291 |
0 |
355 |
0 |
82.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
753 |
0 |
878 |
0 |
85.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
669 |
0 |
727 |
0 |
92.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
307 |
0 |
408 |
0 |
75.30% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
94 |
0 |
283 |
0 |
33.20% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
192 |
0 |
283 |
0 |
67.80% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
265 |
0 |
283 |
0 |
93.60% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
84 |
0 |
108 |
0 |
77.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
48 |
0 |
82 |
0 |
58.50% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
298 |
0 |
325 |
0 |
91.70% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
42 |
0 |
50 |
0 |
84.00% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
65 |
0 |
191 |
0 |
34.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
216 |
0 |
967 |
0 |
22.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
253 |
0 |
496 |
0 |
51.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
39 |
0 |
54 |
0 |
72.20% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
41 |
0 |
54 |
0 |
75.90% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
1176 |
0 |
6353 |
0 |
18.50% |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Davis Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
11723 |
0 |
11996 |
0 |
97.70% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
341 |
0 |
361 |
0 |
94.50% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Davis Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
48 |
0 |
42.8 |
0 |
1.1215 |
0 |
1 |
No |
PY4 |
DPH |
UC Davis Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
52 |
0 |
97.67 |
0 |
0.532 |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
956 |
0 |
957 |
0 |
99.90% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
35 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
342 |
0 |
1054 |
0 |
32.50% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
567 |
0 |
1079 |
0 |
52.60% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
3126 |
0 |
5849 |
0 |
53.50% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
2831 |
0 |
6299 |
0 |
44.90% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
256 |
0 |
465 |
0 |
55.10% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
499 |
0 |
778 |
0 |
64.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
3003 |
0 |
5759 |
0 |
52.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
606 |
0 |
1364 |
0 |
44.40% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
4838 |
0 |
8206 |
0 |
59.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
103 |
0 |
264 |
0 |
39.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
214 |
0 |
465 |
0 |
46.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
9085 |
0 |
15115 |
0 |
60.10% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
8880 |
0 |
20481 |
0 |
43.40% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
9266 |
0 |
17209 |
0 |
53.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
21706 |
0 |
22446 |
0 |
96.70% |
0 |
1 |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
544 |
0 |
1676 |
0 |
32.50% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
20331 |
0 |
22203 |
0 |
91.60% |
0 |
1 |
Nos |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
3283 |
0 |
3337 |
0 |
98.40% |
0 |
1 |
YesS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
2723 |
0 |
3337 |
0 |
81.60% |
0 |
1 |
YesS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
2717 |
0 |
3337 |
0 |
81.40% |
0 |
1 |
YesS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
273 |
0 |
421 |
0 |
64.90% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
116 |
0 |
183 |
0 |
63.40% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
16 |
0 |
292 |
0 |
5.50% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
58 |
0 |
194 |
0 |
29.90% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
27 |
0 |
194 |
0 |
13.90% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
33 |
0 |
194 |
0 |
17.00% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH3 |
Q-FUA |
? 30 Days |
Reported |
0.00% |
0 |
10.80% |
0 |
None |
1 |
35 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH3 |
Q-FUA |
? 7 Days |
Reported |
0.00% |
0 |
7.10% |
0 |
None |
1 |
35 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
UC Irvine Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Reported |
0.00% |
0 |
4.70% |
0 |
12 |
0 |
252 |
0 |
4.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
680 |
0 |
1173 |
0 |
58.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
291 |
0 |
336 |
0 |
86.60% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
74 |
0 |
82 |
0 |
90.20% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
449 |
0 |
1400 |
0 |
32.10% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
438 |
0 |
1400 |
0 |
31.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
1265 |
0 |
1400 |
0 |
90.40% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
251 |
0 |
340 |
0 |
73.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
122 |
0 |
173 |
0 |
70.50% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
308 |
0 |
314 |
0 |
98.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
687 |
0 |
1246 |
0 |
55.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
300 |
0 |
358 |
0 |
83.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
46 |
0 |
262 |
0 |
17.60% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
1536 |
0 |
5589 |
0 |
27.50% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
103 |
0 |
170 |
0 |
60.60% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
366 |
0 |
445 |
0 |
82.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
335 |
0 |
445 |
0 |
75.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
3988 |
0 |
7750 |
0 |
51.50% |
0 |
1 |
No |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
11615 |
0 |
11950 |
0 |
97.20% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Irvine Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
30 |
0 |
30 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
1 |
None |
1 |
0 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
4 |
None |
1 |
0 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-IHE1 |
Q-IHE1 |
? Colorectal Cancer Screening - -Native Hawaiian/Pacific Islander |
Reported |
0.00% |
0 |
27.40% |
0 |
None |
1 |
33 |
0 |
None |
1 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
52 |
0 |
98 |
0 |
53.10% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
129 |
0 |
234 |
0 |
55.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
2054 |
0 |
3907 |
0 |
52.60% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
75 |
0 |
189 |
0 |
39.70% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
86 |
0 |
156 |
0 |
55.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
4282 |
0 |
12745 |
0 |
33.60% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
67 |
0 |
399 |
0 |
16.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
459 |
0 |
1084 |
0 |
42.30% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
83 |
0 |
233 |
0 |
35.60% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
95 |
0 |
189 |
0 |
50.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
9767 |
0 |
26501 |
0 |
36.90% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
11857 |
0 |
24465 |
0 |
48.50% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
8256 |
0 |
32188 |
0 |
25.70% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
22952 |
0 |
24301 |
0 |
94.50% |
0 |
N/A |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
438 |
0 |
1463 |
0 |
29.90% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
21606 |
0 |
23980 |
0 |
90.10% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
756 |
0 |
2377 |
0 |
31.80% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
405 |
0 |
2377 |
0 |
17.00% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
412 |
0 |
2377 |
0 |
17.30% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
107 |
0 |
180 |
0 |
59.40% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
21 |
0 |
39 |
0 |
53.90% |
0 |
1 |
NoS |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
56 |
0 |
79 |
0 |
70.90% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
649 |
0 |
804 |
0 |
80.70% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
1538 |
0 |
1755 |
0 |
87.60% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
334 |
0 |
405 |
0 |
82.50% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
51 |
0 |
80 |
0 |
63.80% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
15 |
0 |
51 |
0 |
29.40% |
0 |
1 |
Yes |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
19 |
0 |
51 |
0 |
37.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
44 |
0 |
51 |
0 |
86.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
207 |
0 |
325 |
0 |
63.70% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
57 |
0 |
80 |
0 |
71.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
92 |
0 |
94 |
0 |
97.90% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
428 |
0 |
466 |
0 |
91.90% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
35 |
0 |
129 |
0 |
27.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
125 |
0 |
795 |
0 |
15.70% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
164 |
0 |
334 |
0 |
49.10% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
6271 |
0 |
13482 |
0 |
46.50% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
13292 |
0 |
20346 |
0 |
65.30% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
3427 |
0 |
6856 |
0 |
50.00% |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
27.933 |
0 |
2088 |
0 |
0.0134 |
0 |
1 |
No |
PY4 |
DPH |
UC Los Angeles Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
141 |
0 |
157.089 |
0 |
0.898 |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
136 |
0 |
136 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
4 |
None |
1 |
N/A |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
39 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
121 |
0 |
204 |
0 |
59.30% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
458 |
0 |
768 |
0 |
59.60% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
595 |
0 |
1275 |
0 |
46.70% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
26 |
0 |
164 |
0 |
15.90% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
19 |
0 |
34 |
0 |
55.90% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
1512 |
0 |
2009 |
0 |
75.30% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
142 |
0 |
329 |
0 |
43.20% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
600 |
0 |
1085 |
0 |
55.30% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
None |
1 |
40 |
0 |
None |
1 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
2535 |
0 |
4432 |
0 |
57.20% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
12046 |
0 |
23502 |
0 |
51.30% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
1799 |
0 |
2716 |
0 |
66.20% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
31354 |
0 |
33597 |
0 |
93.30% |
0 |
N/A |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
1613 |
0 |
3712 |
0 |
43.50% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
28765 |
0 |
33107 |
0 |
86.90% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
411 |
0 |
631 |
0 |
65.10% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
388 |
0 |
631 |
0 |
61.50% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
379 |
0 |
631 |
0 |
60.10% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
70 |
0 |
108 |
0 |
64.80% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
22 |
0 |
53 |
0 |
41.50% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Diego Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
162 |
0 |
246 |
0 |
65.90% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
49 |
0 |
56 |
0 |
87.50% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
100 |
0 |
116 |
0 |
86.20% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
43 |
0 |
43 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
286 |
0 |
462 |
0 |
61.90% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
40 |
0 |
174 |
0 |
23.00% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
102 |
0 |
174 |
0 |
58.60% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
156 |
0 |
174 |
0 |
89.70% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
123 |
0 |
153 |
0 |
80.40% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
39 |
0 |
46 |
0 |
84.80% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Diego Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
415 |
0 |
936 |
0 |
44.30% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
None |
1 |
42 |
0 |
None |
1 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
108 |
0 |
436 |
0 |
24.80% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
152 |
0 |
556 |
0 |
27.30% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
789 |
0 |
1095 |
0 |
72.10% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
16 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
13 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
3858 |
0 |
9242 |
0 |
41.70% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
655 |
0 |
709 |
0 |
92.40% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
16259 |
0 |
16691 |
0 |
97.40% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
3945 |
0 |
6619 |
0 |
59.60% |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
30 |
0 |
46.024 |
0 |
0.6518 |
0 |
1 |
No |
PY4 |
DPH |
UC San Diego Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
127 |
0 |
145.81 |
0 |
0.871 |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
626 |
0 |
626 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
44 |
0 |
43.758 |
0 |
1.006 |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
51 |
0 |
173 |
0 |
29.50% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
32 |
0 |
113 |
0 |
28.30% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-IHE2 |
Q-IHE2 |
? Controlling High Blood Pressure (CBP) - -Black/African American |
Reported |
0.00% |
0 |
50.60% |
0 |
131 |
0 |
239 |
0 |
54.80% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
681 |
0 |
1229 |
0 |
55.40% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
2312 |
0 |
3583 |
0 |
64.50% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
2428 |
0 |
3840 |
0 |
63.20% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
131 |
0 |
258 |
0 |
50.80% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
172 |
0 |
334 |
0 |
51.50% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
2923 |
0 |
4386 |
0 |
66.60% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
340 |
0 |
618 |
0 |
55.00% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
3795 |
0 |
5269 |
0 |
72.00% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
94 |
0 |
266 |
0 |
35.30% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
17796 |
0 |
27647 |
0 |
64.40% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
4753 |
0 |
8022 |
0 |
59.30% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
25125 |
0 |
25747 |
0 |
97.60% |
0 |
N/A |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
1100 |
0 |
2473 |
0 |
44.50% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
23423 |
0 |
25418 |
0 |
92.20% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
161 |
0 |
233 |
0 |
69.10% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
67 |
0 |
105 |
0 |
63.80% |
0 |
1 |
NoS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
170 |
0 |
324 |
0 |
52.50% |
0 |
1 |
YesS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
32 |
0 |
324 |
0 |
9.90% |
0 |
1 |
YesS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
55 |
0 |
324 |
0 |
17.00% |
0 |
1 |
YesS |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
None |
1 |
None |
4 |
None |
1 |
N/A |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
643 |
0 |
1042 |
0 |
61.70% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
182 |
0 |
194 |
0 |
93.80% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
320 |
0 |
332 |
0 |
96.40% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
105 |
0 |
108 |
0 |
97.20% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
1006 |
0 |
1371 |
0 |
73.40% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
202 |
0 |
816 |
0 |
24.80% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
451 |
0 |
804 |
0 |
56.10% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
738 |
0 |
815 |
0 |
90.60% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
498 |
0 |
552 |
0 |
90.20% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
136 |
0 |
225 |
0 |
60.40% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
207 |
0 |
211 |
0 |
98.10% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
29 |
0 |
124 |
0 |
23.40% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Reported |
0.00% |
0 |
19.70% |
0 |
881 |
0 |
2860 |
0 |
30.80% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
153 |
0 |
242 |
0 |
63.20% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
117 |
0 |
145 |
0 |
80.70% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
81 |
0 |
145 |
0 |
55.90% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
8686 |
0 |
11040 |
0 |
78.70% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
357 |
0 |
357 |
0 |
100.00% |
0 |
1 |
Yes |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
12716 |
0 |
12873 |
0 |
98.80% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
4533 |
0 |
4958 |
0 |
91.40% |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
37 |
0 |
56.886 |
0 |
0.6504 |
0 |
1 |
No |
PY4 |
DPH |
UC San Francisco Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
101 |
0 |
108.54 |
0 |
0.931 |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
1453 |
0 |
1529 |
0 |
95.00% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
24 |
0 |
63 |
0 |
38.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Ventura County Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
695 |
0 |
1894 |
0 |
36.70% |
0 |
1 |
NoS |
PY4 |
DPH |
Ventura County Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
1881 |
0 |
3524 |
0 |
53.40% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
8461 |
0 |
15995 |
0 |
52.90% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
13925 |
0 |
35545 |
0 |
39.20% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
637 |
0 |
1687 |
0 |
37.80% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
1393 |
0 |
2717 |
0 |
51.30% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
4447 |
0 |
9615 |
0 |
46.30% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
1415 |
0 |
3411 |
0 |
41.50% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
13348 |
0 |
26007 |
0 |
51.30% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
714 |
0 |
2188 |
0 |
32.60% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
823 |
0 |
1695 |
0 |
48.60% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
18226 |
0 |
31358 |
0 |
58.10% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
16076 |
0 |
29653 |
0 |
54.20% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
16538 |
0 |
30020 |
0 |
55.10% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
26581 |
0 |
26761 |
0 |
99.30% |
0 |
N/A |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
1153 |
0 |
2231 |
0 |
51.70% |
0 |
1 |
YesS |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
25359 |
0 |
26760 |
0 |
94.80% |
0 |
1 |
YesS |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
1104 |
0 |
1659 |
0 |
66.60% |
0 |
1 |
NoS |
PY4 |
DPH |
Ventura County Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
242 |
0 |
334 |
0 |
72.50% |
0 |
1 |
NoS |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
Reported |
0.00% |
0 |
36.10% |
0 |
270 |
0 |
714 |
0 |
37.80% |
0 |
1 |
NoS |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
Reported |
0.00% |
0 |
4.10% |
0 |
62 |
0 |
714 |
0 |
8.70% |
0 |
1 |
NoS |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
Reported |
0.00% |
0 |
9.60% |
0 |
108 |
0 |
714 |
0 |
15.10% |
0 |
1 |
NoS |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
Reported |
0.00% |
0 |
30.00% |
0 |
44 |
0 |
170 |
0 |
25.90% |
0 |
N/A |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
Reported |
0.00% |
0 |
4.80% |
0 |
11 |
0 |
170 |
0 |
6.50% |
0 |
N/A |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
Reported |
0.00% |
0 |
9.50% |
0 |
20 |
0 |
170 |
0 |
11.80% |
0 |
N/A |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
2206 |
0 |
4050 |
0 |
54.50% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
134 |
0 |
159 |
0 |
84.30% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
314 |
0 |
362 |
0 |
86.70% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
47 |
0 |
49 |
0 |
95.90% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
2378 |
0 |
3569 |
0 |
66.60% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
1103 |
0 |
3091 |
0 |
35.70% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
1506 |
0 |
3091 |
0 |
48.70% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
2623 |
0 |
3091 |
0 |
84.90% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Reported |
0.00% |
0 |
77.10% |
0 |
130 |
0 |
225 |
0 |
57.80% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
544 |
0 |
957 |
0 |
56.80% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
970 |
0 |
984 |
0 |
98.60% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
77 |
0 |
81 |
0 |
95.10% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
62 |
0 |
91 |
0 |
68.10% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
1230 |
0 |
1516 |
0 |
81.10% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
50 |
0 |
269 |
0 |
18.60% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
616 |
0 |
913 |
0 |
67.50% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
655 |
0 |
831 |
0 |
78.80% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
704 |
0 |
831 |
0 |
84.70% |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DPH |
Ventura County Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
1874 |
0 |
1902 |
0 |
98.50% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
125 |
0 |
250 |
0 |
50.00% |
0 |
1 |
Yes |
PY4 |
DPH |
Ventura County Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
5 |
0 |
6.585 |
0 |
0.7593 |
0 |
1 |
No |
PY4 |
DPH |
Ventura County Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
13 |
0 |
12.58 |
0 |
1.033 |
0 |
1 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
4939 |
0 |
6806 |
0 |
72.60% |
0 |
0.5 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
262 |
0 |
221.579 |
0 |
1.182 |
0 |
0.5 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-BH3 |
Q-FUA |
? 30 Days |
Reported |
0.00% |
0 |
10.80% |
0 |
64 |
0 |
339 |
0 |
18.90% |
0 |
0.5 |
NoS |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-BH3 |
Q-FUA |
? 7 Days |
Reported |
0.00% |
0 |
7.10% |
0 |
70 |
0 |
339 |
0 |
20.70% |
0 |
0.5 |
NoS |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
Reported |
0.00% |
0 |
63.60% |
0 |
126 |
0 |
165 |
0 |
76.40% |
0 |
0.5 |
NoS |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
Reported |
0.00% |
0 |
78.70% |
0 |
150 |
0 |
165 |
0 |
90.90% |
0 |
0.5 |
NoS |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
16 |
0 |
305 |
0 |
5.30% |
0 |
0 |
Yes |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Reported |
0.00% |
0 |
47.60% |
0 |
None |
1 |
66 |
0 |
None |
1 |
0 |
Yes |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
177 |
0 |
218 |
0 |
81.20% |
0 |
1 |
Yes |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
390 |
0 |
1207 |
0 |
32.30% |
0 |
0.5 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
151 |
0 |
619 |
0 |
24.40% |
0 |
1 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
401 |
0 |
761 |
0 |
52.70% |
0 |
1 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
165 |
0 |
1911 |
0 |
8.60% |
0 |
0.5 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
94 |
0 |
180 |
0 |
52.20% |
0 |
1 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
712 |
0 |
1076 |
0 |
66.20% |
0 |
1 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
10 |
0 |
15.648 |
0 |
0.6391 |
0 |
1 |
No |
PY4 |
DMPH |
Antelope Valley Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
38 |
0 |
57.431 |
0 |
0.662 |
0 |
1 |
No |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC15 |
Q-WCC |
? BMI |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PC16 |
Q-W30 |
? First 15 Months |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH3 |
Q-FUA |
? 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH3 |
Q-FUA |
? 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Bear Valley Community Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
120 |
0 |
227 |
0 |
52.90% |
0 |
1 |
No |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
108 |
0 |
340 |
0 |
31.80% |
0 |
1 |
No |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Eastern Plumas Health Care |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
73 |
0 |
95 |
0 |
76.80% |
0 |
1 |
No |
PY4 |
DMPH |
El Camino Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
31 |
0 |
108 |
0 |
28.70% |
0 |
1 |
No |
PY4 |
DMPH |
El Camino Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
126 |
0 |
293 |
0 |
43.00% |
0 |
1 |
No |
PY4 |
DMPH |
El Camino Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
30 |
0 |
30 |
0 |
100.00% |
0 |
1 |
Yes |
PY4 |
DMPH |
El Camino Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
21 |
0 |
30 |
0 |
70.00% |
0 |
1 |
No |
PY4 |
DMPH |
El Camino Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
699 |
0 |
1207 |
0 |
57.90% |
0 |
1 |
No |
PY4 |
DMPH |
El Camino Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
283 |
0 |
283 |
0 |
100.00% |
0 |
1 |
Yes |
PY4 |
DMPH |
El Camino Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
5288 |
0 |
5366 |
0 |
98.60% |
0 |
1 |
No |
PY4 |
DMPH |
El Camino Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Camino Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
6 |
0 |
15.339 |
0 |
0.3912 |
0 |
1 |
No |
PY4 |
DMPH |
El Camino Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
27 |
0 |
58.836 |
0 |
0.459 |
0 |
1 |
Yes |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
196 |
0 |
724 |
0 |
27.10% |
0 |
1 |
NoS |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
428 |
0 |
701 |
0 |
61.10% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
488 |
0 |
2171 |
0 |
22.50% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
15 |
0 |
61 |
0 |
24.60% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
129 |
0 |
254 |
0 |
50.80% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
607 |
0 |
1859 |
0 |
32.70% |
0 |
1 |
Yes |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
38 |
0 |
105 |
0 |
36.20% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
52 |
0 |
69 |
0 |
75.40% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
3826 |
0 |
4011 |
0 |
95.40% |
0 |
1 |
Yes |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
4060 |
0 |
4417 |
0 |
91.90% |
0 |
1 |
Yes |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
4016 |
0 |
4272 |
0 |
94.00% |
0 |
N/A |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
276 |
0 |
439 |
0 |
62.90% |
0 |
1 |
NoS |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
3853 |
0 |
4272 |
0 |
90.20% |
0 |
1 |
NoS |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
1282 |
0 |
1426 |
0 |
89.90% |
0 |
1 |
NoS |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
1273 |
0 |
1426 |
0 |
89.30% |
0 |
1 |
NoS |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
1273 |
0 |
1426 |
0 |
89.30% |
0 |
1 |
NoS |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
708 |
0 |
1020 |
0 |
69.40% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
134 |
0 |
191 |
0 |
70.20% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
210 |
0 |
752 |
0 |
27.90% |
0 |
1 |
Yes |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
96 |
0 |
752 |
0 |
12.80% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
34 |
0 |
70 |
0 |
48.60% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
205 |
0 |
455 |
0 |
45.10% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
152 |
0 |
196 |
0 |
77.60% |
0 |
1 |
No |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
El Centro Regional Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
7 |
0 |
17.7 |
0 |
0.396 |
0 |
1 |
No |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
58 |
0 |
134 |
0 |
43.30% |
0 |
1 |
No |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
612 |
0 |
1027 |
0 |
59.60% |
0 |
1 |
Yes |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
740 |
0 |
1753 |
0 |
42.20% |
0 |
1 |
Yes |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
41 |
0 |
138 |
0 |
29.70% |
0 |
1 |
No |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
123 |
0 |
192 |
0 |
64.10% |
0 |
1 |
No |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
68 |
0 |
187 |
0 |
36.40% |
0 |
1 |
No |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
18 |
0 |
76 |
0 |
23.70% |
0 |
1 |
No |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
175 |
0 |
246 |
0 |
71.10% |
0 |
1 |
No |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
68 |
0 |
85 |
0 |
80.00% |
0 |
1 |
No |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Hazel Hawkins Memorial Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC15 |
Q-WCC |
? BMI |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PC16 |
Q-W30 |
? First 15 Months |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH3 |
Q-FUA |
? 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH3 |
Q-FUA |
? 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Healdsburg District Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
18 |
0 |
65 |
0 |
27.70% |
0 |
1 |
No |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
84 |
0 |
214 |
0 |
39.30% |
0 |
1 |
No |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
51 |
0 |
118 |
0 |
43.20% |
0 |
1 |
Yes |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
80 |
0 |
263 |
0 |
30.40% |
0 |
1 |
No |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
31 |
0 |
216 |
0 |
14.40% |
0 |
1 |
No |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
237 |
0 |
241 |
0 |
98.30% |
0 |
N/A |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
48 |
0 |
60 |
0 |
80.00% |
0 |
1 |
NoS |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
220 |
0 |
241 |
0 |
91.30% |
0 |
1 |
NoS |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Jerold Phelps Community Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
140 |
0 |
676 |
0 |
20.70% |
0 |
1 |
No |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
None |
1 |
43 |
0 |
None |
1 |
1 |
No |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
None |
1 |
134 |
0 |
None |
1 |
1 |
No |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
22 |
0 |
114 |
0 |
19.30% |
0 |
1 |
No |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
199 |
0 |
1705 |
0 |
11.70% |
0 |
1 |
Yes |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
None |
1 |
45 |
0 |
None |
1 |
1 |
No |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
John C. Fremont Healthcare District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
166 |
0 |
459 |
0 |
36.20% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
241 |
0 |
472 |
0 |
51.10% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
1635 |
0 |
3003 |
0 |
54.50% |
0 |
1 |
Yes |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
115 |
0 |
395 |
0 |
29.10% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
145 |
0 |
478 |
0 |
30.30% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
432 |
0 |
1993 |
0 |
21.70% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Reported |
0.00% |
0 |
9.40% |
0 |
1395 |
0 |
5333 |
0 |
26.20% |
0 |
1 |
Yes |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
1370 |
0 |
7152 |
0 |
19.20% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
3016 |
0 |
6953 |
0 |
43.40% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
13779 |
0 |
14366 |
0 |
95.90% |
0 |
1 |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
80 |
0 |
2114 |
0 |
3.80% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
11745 |
0 |
14366 |
0 |
81.80% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
2747 |
0 |
4102 |
0 |
67.00% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
1302 |
0 |
4102 |
0 |
31.70% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
1243 |
0 |
4102 |
0 |
30.30% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
248 |
0 |
362 |
0 |
68.50% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
63 |
0 |
100 |
0 |
63.00% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Reported |
0.00% |
0 |
14.70% |
0 |
44 |
0 |
318 |
0 |
13.80% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-BH3 |
Q-FUA |
? 30 Days |
Reported |
0.00% |
0 |
10.80% |
0 |
None |
1 |
35 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-BH3 |
Q-FUA |
? 7 Days |
Reported |
0.00% |
0 |
7.10% |
0 |
None |
1 |
35 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
763 |
0 |
1011 |
0 |
75.50% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
250 |
0 |
716 |
0 |
34.90% |
0 |
1 |
Yes |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
410 |
0 |
716 |
0 |
57.30% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
211 |
0 |
251 |
0 |
84.10% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
206 |
0 |
251 |
0 |
82.10% |
0 |
1 |
Yes |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
627 |
0 |
868 |
0 |
72.20% |
0 |
1 |
No |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kaweah Delta Health Care District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
78 |
0 |
273 |
0 |
28.60% |
0 |
1 |
No |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
124 |
0 |
452 |
0 |
27.40% |
0 |
1 |
Yes |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
237 |
0 |
960 |
0 |
24.70% |
0 |
1 |
No |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
385 |
0 |
418 |
0 |
92.10% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
203 |
0 |
418 |
0 |
48.60% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
85 |
0 |
418 |
0 |
20.30% |
0 |
1 |
NoS |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
None |
1 |
39 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
None |
1 |
34 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
22 |
0 |
72 |
0 |
30.60% |
0 |
1 |
No |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Kern Valley Healthcare District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
1 |
None |
1 |
N/A |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
20 |
0 |
60 |
0 |
33.30% |
0 |
1 |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
114 |
0 |
228 |
0 |
50.00% |
0 |
1 |
Yes |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
374 |
0 |
705 |
0 |
53.10% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
1150 |
0 |
2150 |
0 |
53.50% |
0 |
1 |
Yes |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
54 |
0 |
139 |
0 |
38.90% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
148 |
0 |
1006 |
0 |
14.70% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
28 |
0 |
112 |
0 |
25.00% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
53 |
0 |
162 |
0 |
32.70% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
1171 |
0 |
3713 |
0 |
31.50% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
765 |
0 |
3881 |
0 |
19.70% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
178 |
0 |
4362 |
0 |
4.10% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
1899 |
0 |
2453 |
0 |
77.40% |
0 |
N/A |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
112 |
0 |
255 |
0 |
43.90% |
0 |
1 |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
1654 |
0 |
2453 |
0 |
67.40% |
0 |
1 |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
1419 |
0 |
1818 |
0 |
78.10% |
0 |
1 |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
386 |
0 |
1818 |
0 |
21.20% |
0 |
1 |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
149 |
0 |
1818 |
0 |
8.20% |
0 |
1 |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
13 |
0 |
None |
4 |
None |
4 |
1 |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
34 |
0 |
40 |
0 |
85.00% |
0 |
1 |
NoS |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
167 |
0 |
271 |
0 |
61.60% |
0 |
1 |
Yes |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
15 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
24 |
0 |
33 |
0 |
72.70% |
0 |
1 |
Yes |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
180 |
0 |
307 |
0 |
58.60% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
30 |
0 |
133 |
0 |
22.60% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
50 |
0 |
53 |
0 |
94.30% |
0 |
1 |
No |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Lompoc Valley Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
4 |
0 |
4.41 |
0 |
0.907 |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
53 |
0 |
111 |
0 |
47.80% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
203 |
0 |
416 |
0 |
48.80% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
375 |
0 |
958 |
0 |
39.10% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
25 |
0 |
32 |
0 |
78.10% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
29 |
0 |
53 |
0 |
54.70% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
178 |
0 |
397 |
0 |
44.80% |
0 |
1 |
Yes |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
459 |
0 |
1295 |
0 |
35.40% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
659 |
0 |
1399 |
0 |
47.10% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
1056 |
0 |
1079 |
0 |
97.90% |
0 |
1 |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
21 |
0 |
111 |
0 |
18.90% |
0 |
1 |
NoS |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
966 |
0 |
1079 |
0 |
89.50% |
0 |
1 |
NoS |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
38 |
0 |
69 |
0 |
55.10% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
40 |
0 |
60 |
0 |
66.70% |
0 |
1 |
No |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
15 |
0 |
61 |
0 |
24.60% |
0 |
1 |
Yes |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mammoth Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
246 |
0 |
379 |
0 |
64.90% |
0 |
1 |
No |
PY4 |
DMPH |
Marin General Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Marin General Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Marin General Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
61 |
0 |
177 |
0 |
34.50% |
0 |
1 |
NoS |
PY4 |
DMPH |
Marin General Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
183 |
0 |
301 |
0 |
60.80% |
0 |
1 |
Yes |
PY4 |
DMPH |
Marin General Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
96 |
0 |
270 |
0 |
35.60% |
0 |
1 |
No |
PY4 |
DMPH |
Marin General Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
30 |
0 |
180 |
0 |
16.70% |
0 |
1 |
No |
PY4 |
DMPH |
Marin General Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
98 |
0 |
129 |
0 |
76.00% |
0 |
1 |
No |
PY4 |
DMPH |
Marin General Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
302 |
0 |
1912 |
0 |
15.80% |
0 |
1 |
No |
PY4 |
DMPH |
Marin General Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
106 |
0 |
108 |
0 |
98.20% |
0 |
1 |
No |
PY4 |
DMPH |
Marin General Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
528 |
0 |
735 |
0 |
71.80% |
0 |
1 |
Yes |
PY4 |
DMPH |
Marin General Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Marin General Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
5 |
0 |
23.431 |
0 |
0.213 |
0 |
1 |
No |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
No |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mayers Memorial Hospital District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
0 |
0 |
0.485 |
0 |
0 |
0 |
1 |
No |
PY4 |
DMPH |
Modoc Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
495 |
0 |
878 |
0 |
56.40% |
0 |
1 |
No |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
666 |
0 |
721 |
0 |
92.40% |
0 |
1 |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
163 |
0 |
233 |
0 |
70.00% |
0 |
1 |
NoS |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
594 |
0 |
719 |
0 |
82.60% |
0 |
1 |
NoS |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Modoc Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
83 |
0 |
160 |
0 |
51.90% |
0 |
1 |
No |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
798 |
0 |
1652 |
0 |
48.30% |
0 |
1 |
No |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
68 |
0 |
94 |
0 |
72.30% |
0 |
1 |
No |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
46 |
0 |
69 |
0 |
66.70% |
0 |
1 |
No |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Northern Inyo Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
2790 |
0 |
2790 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
59 |
0 |
218 |
0 |
27.10% |
0 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
66 |
0 |
124 |
0 |
53.20% |
0 |
1 |
Yes |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
171 |
0 |
314 |
0 |
54.50% |
0 |
1 |
Yes |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
353 |
0 |
1564 |
0 |
22.60% |
0 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
0 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
965 |
0 |
1741 |
0 |
55.40% |
0 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
0 |
0 |
36 |
0 |
0.00% |
0 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
0 |
0 |
None |
1 |
None |
1 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Reported |
0.00% |
0 |
61.30% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
512 |
0 |
2875 |
0 |
17.80% |
0 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
658 |
0 |
2062 |
0 |
31.90% |
0 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
181 |
0 |
353 |
0 |
51.30% |
0 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
1414 |
0 |
1449 |
0 |
97.60% |
0 |
1 |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
185 |
0 |
215 |
0 |
86.10% |
0 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
1381 |
0 |
1414 |
0 |
97.70% |
0 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
None |
1 |
1256 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
None |
1 |
1256 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
None |
1 |
1256 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
0 |
0 |
None |
1 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
0 |
0 |
0 |
0 |
0.00% |
0 |
1 |
NoS |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Reported |
0.00% |
0 |
66.70% |
0 |
406 |
0 |
598 |
0 |
67.90% |
0 |
1 |
Yes |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
0 |
0 |
388 |
0 |
0.00% |
0 |
1 |
No |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
344 |
0 |
388 |
0 |
88.70% |
0 |
1 |
Yes |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Oak Valley Hospital District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
119 |
0 |
324 |
0 |
36.70% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DMPH |
Palomar Health |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
4 |
None |
1 |
N/A |
NoS |
PY4 |
DMPH |
Palomar Health |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
46 |
0 |
178 |
0 |
25.80% |
0 |
1 |
NoS |
PY4 |
DMPH |
Palomar Health |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
33 |
0 |
52 |
0 |
63.50% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
36 |
0 |
101 |
0 |
35.60% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Reported |
0.00% |
0 |
60.40% |
0 |
28 |
0 |
31 |
0 |
90.30% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
97 |
0 |
411 |
0 |
23.60% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
37 |
0 |
53 |
0 |
69.80% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
317 |
0 |
392 |
0 |
80.90% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
73 |
0 |
402 |
0 |
18.20% |
0 |
1 |
Yes |
PY4 |
DMPH |
Palomar Health |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
196 |
0 |
405 |
0 |
48.40% |
0 |
1 |
Yes |
PY4 |
DMPH |
Palomar Health |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Palomar Health |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
25 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
204 |
0 |
204 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
228 |
0 |
372 |
0 |
61.30% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
2311 |
0 |
2339 |
0 |
98.80% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
115 |
0 |
654 |
0 |
17.60% |
0 |
1 |
No |
PY4 |
DMPH |
Palomar Health |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
10 |
0 |
14.562 |
0 |
0.6867 |
0 |
1 |
Yes |
PY4 |
DMPH |
Palomar Health |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
17 |
0 |
47.563 |
0 |
0.357 |
0 |
1 |
Yes |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
1107 |
0 |
2006 |
0 |
55.20% |
0 |
1 |
Yes |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
754 |
0 |
1919 |
0 |
39.30% |
0 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
34 |
0 |
95 |
0 |
35.80% |
0 |
1 |
Yes |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
99 |
0 |
189 |
0 |
52.40% |
0 |
1 |
Yes |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
0 |
0 |
2323 |
0 |
0.00% |
0 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
786 |
0 |
1253 |
0 |
62.70% |
0 |
1 |
NoS |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
291 |
0 |
1253 |
0 |
23.20% |
0 |
1 |
NoS |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
122 |
0 |
1253 |
0 |
9.70% |
0 |
1 |
Nos |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
N/A |
0 |
106 |
0 |
170 |
0 |
62.40% |
0 |
1 |
NoS |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
N/A |
0 |
34 |
0 |
66 |
0 |
51.50% |
0 |
1 |
NoS |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
343 |
0 |
693 |
0 |
49.50% |
0 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
246 |
0 |
481 |
0 |
51.10% |
0 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
254 |
0 |
481 |
0 |
52.80% |
0 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
79 |
0 |
127 |
0 |
62.20% |
0 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
93 |
0 |
127 |
0 |
73.20% |
0 |
1 |
No |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Pioneers Memorial Healthcare District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
206 |
0 |
1189 |
0 |
17.30% |
0 |
1 |
No |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
750 |
0 |
1057 |
0 |
71.00% |
0 |
1 |
No |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Plumas District Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
466 |
0 |
980 |
0 |
47.60% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
3322 |
0 |
5843 |
0 |
56.90% |
0 |
1 |
Yes |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
1389 |
0 |
3246 |
0 |
42.80% |
0 |
1 |
Yes |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
44 |
0 |
137 |
0 |
32.10% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
134 |
0 |
213 |
0 |
62.90% |
0 |
1 |
Yes |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
1521 |
0 |
4693 |
0 |
32.40% |
0 |
1 |
Yes |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
56 |
0 |
162 |
0 |
34.60% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
4111 |
0 |
16364 |
0 |
25.10% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
5064 |
0 |
14816 |
0 |
34.20% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
1671 |
0 |
15164 |
0 |
11.00% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
12955 |
0 |
14340 |
0 |
90.30% |
0 |
N/A |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
300 |
0 |
1477 |
0 |
20.30% |
0 |
1 |
NoS |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
11778 |
0 |
14340 |
0 |
82.10% |
0 |
1 |
NoS |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
185 |
0 |
1416 |
0 |
13.10% |
0 |
1 |
NoS |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
None |
1 |
1416 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
37 |
0 |
1416 |
0 |
2.60% |
0 |
1 |
NoS |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
93 |
0 |
139 |
0 |
66.90% |
0 |
1 |
NoS |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
47 |
0 |
116 |
0 |
40.50% |
0 |
1 |
NoS |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
530 |
0 |
1017 |
0 |
52.10% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Reported |
0.00% |
0 |
66.90% |
0 |
151 |
0 |
163 |
0 |
92.60% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
250 |
0 |
290 |
0 |
86.20% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
309 |
0 |
858 |
0 |
36.00% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
260 |
0 |
282 |
0 |
92.20% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
137 |
0 |
192 |
0 |
71.40% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
141 |
0 |
192 |
0 |
73.40% |
0 |
1 |
No |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Salinas Valley Memorial Healthcare System |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
0 |
0 |
16 |
0 |
0 |
0 |
1 |
No |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
61 |
0 |
115 |
0 |
53.00% |
0 |
1 |
Yes |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
254 |
0 |
681 |
0 |
37.30% |
0 |
1 |
Yes |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Reported |
0.00% |
0 |
49.60% |
0 |
883 |
0 |
1365 |
0 |
64.70% |
0 |
1 |
No |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
758 |
0 |
1461 |
0 |
51.90% |
0 |
1 |
No |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
60 |
0 |
103 |
0 |
58.30% |
0 |
1 |
No |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
17 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
18 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Mountains Community Hospital, Lake Arrowhead |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
653 |
0 |
845 |
0 |
77.30% |
0 |
0.5 |
No |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Reported |
0.00% |
0 |
100.00% |
0 |
35 |
0 |
12.876 |
0 |
2.718 |
0 |
0.5 |
No |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0.5 |
No |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
Reported |
0.00% |
0 |
63.60% |
0 |
34 |
0 |
40 |
0 |
85.00% |
0 |
0 |
NoS |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
Reported |
0.00% |
0 |
78.70% |
0 |
35 |
0 |
40 |
0 |
87.50% |
0 |
1 |
NoS |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Reported |
0.00% |
0 |
86.30% |
0 |
542 |
0 |
558 |
0 |
97.10% |
0 |
0 |
Yes |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
82 |
0 |
124 |
0 |
66.10% |
0 |
0.5 |
No |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
12 |
0 |
30 |
0 |
40.00% |
0 |
1 |
No |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
21 |
0 |
73 |
0 |
28.80% |
0 |
1 |
No |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
193 |
0 |
193 |
0 |
100.00% |
0 |
1 |
Yes |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
None |
1 |
52 |
0 |
None |
1 |
1 |
No |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Gorgonio Memorial Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
6 |
0 |
7.049 |
0 |
0.851 |
0 |
1 |
No |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
None |
1 |
69 |
0 |
None |
1 |
1 |
No |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
0 |
0 |
130 |
0 |
0.00% |
0 |
1 |
No |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Seneca Healthcare District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
257 |
0 |
4570 |
0 |
5.60% |
0 |
1 |
No |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
4869 |
0 |
5111 |
0 |
95.30% |
0 |
N/A |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
13 |
0 |
672 |
0 |
1.90% |
0 |
1 |
NoS |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
37 |
0 |
5111 |
0 |
0.70% |
0 |
1 |
NoS |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH3 |
Q-FUA |
? 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH3 |
Q-FUA |
? 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
14 |
0 |
130 |
0 |
10.80% |
0 |
1 |
No |
PY4 |
DMPH |
Sierra View District Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
43 |
0 |
184 |
0 |
23.40% |
0 |
1 |
No |
PY4 |
DMPH |
Sierra View District Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
60 |
0 |
116 |
0 |
51.70% |
0 |
1 |
No |
PY4 |
DMPH |
Sierra View District Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Reported |
0.00% |
0 |
18.70% |
0 |
94 |
0 |
125 |
0 |
75.20% |
0 |
1 |
Yes |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
95 |
0 |
98 |
0 |
96.90% |
0 |
1 |
No |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
431 |
0 |
449 |
0 |
96.00% |
0 |
1 |
Yes |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
59 |
0 |
107 |
0 |
55.10% |
0 |
1 |
No |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sierra View District Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
9 |
0 |
11.948 |
0 |
0.753 |
0 |
1 |
No |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
24 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
455 |
0 |
497 |
0 |
91.60% |
0 |
1 |
No |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Sonoma Valley Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
141 |
0 |
798 |
0 |
17.70% |
0 |
1 |
No |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
57 |
0 |
204 |
0 |
27.90% |
0 |
1 |
No |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Southern Inyo Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
30 |
0 |
289 |
0 |
10.40% |
0 |
1 |
No |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
121 |
0 |
234 |
0 |
51.70% |
0 |
0 |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
12 |
0 |
121 |
0 |
9.90% |
0 |
1 |
NoS |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
133 |
0 |
234 |
0 |
56.80% |
0 |
1 |
NoS |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Surprise Valley Community Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
454 |
0 |
750 |
0 |
60.50% |
0 |
1 |
No |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
749 |
0 |
1749 |
0 |
42.80% |
0 |
1 |
Yes |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
1233 |
0 |
3270 |
0 |
37.70% |
0 |
1 |
No |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Reported |
0.00% |
0 |
50.00% |
0 |
733 |
0 |
2079 |
0 |
35.30% |
0 |
1 |
No |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
Reported |
0.00% |
0 |
0.00% |
0 |
2306 |
0 |
2322 |
0 |
99.30% |
0 |
N/A |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
Reported |
0.00% |
0 |
6.70% |
0 |
177 |
0 |
306 |
0 |
57.80% |
0 |
1 |
NoS |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
Reported |
0.00% |
0 |
75.40% |
0 |
2164 |
0 |
2322 |
0 |
93.20% |
0 |
1 |
NoS |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
65 |
0 |
102 |
0 |
63.70% |
0 |
1 |
Yes |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
12 |
0 |
55 |
0 |
21.80% |
0 |
1 |
No |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
26 |
0 |
55 |
0 |
47.30% |
0 |
1 |
No |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
51 |
0 |
55 |
0 |
92.70% |
0 |
1 |
No |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
84 |
0 |
122 |
0 |
68.90% |
0 |
1 |
No |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tahoe Forest Hospital District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Reported |
0.00% |
0 |
44.00% |
0 |
506 |
0 |
937 |
0 |
54.00% |
0 |
1 |
Yes |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
0 |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Reported |
0.00% |
0 |
51.90% |
0 |
None |
1 |
None |
1 |
None |
1 |
0 |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Reported |
0.00% |
0 |
51.90% |
0 |
12 |
0 |
None |
4 |
None |
4 |
0 |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE1 |
Q-IHE1 |
Breast Cancer Screening (BCS) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE1 |
Q-IHE1 |
? Breast Cancer Screening (BCS) - -Black/African American |
Reported |
0.00% |
0 |
48.10% |
0 |
22 |
0 |
44 |
0 |
50.00% |
0 |
1 |
NoS |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE1 |
Q-IHE1 |
? Breast Cancer Screening (BCS) - -White |
Reported |
0.00% |
0 |
48.10% |
0 |
322 |
0 |
502 |
0 |
64.10% |
0 |
1 |
NoS |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-IHE2 |
Q-IHE2 |
? Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) - -Black/African American |
Reported |
0.00% |
0 |
79.30% |
0 |
13 |
0 |
None |
4 |
None |
4 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
507 |
0 |
798 |
0 |
63.50% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-BH3 |
Q-FUA |
? 30 Days |
Reported |
0.00% |
0 |
10.80% |
0 |
None |
1 |
124 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Tri-City Medical Center |
Q-BH3 |
Q-FUA |
? 7 Days |
Reported |
0.00% |
0 |
7.10% |
0 |
None |
1 |
124 |
0 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Tri-City Medical Center |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
145 |
0 |
227 |
0 |
63.90% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
27 |
0 |
68 |
0 |
39.70% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Reported |
0.00% |
0 |
59.90% |
0 |
None |
1 |
31 |
0 |
None |
1 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
Reported |
0.00% |
0 |
63.60% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Tri-City Medical Center |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
Reported |
0.00% |
0 |
78.70% |
0 |
None |
1 |
None |
1 |
None |
1 |
1 |
NoS |
PY4 |
DMPH |
Tri-City Medical Center |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Reported |
0.00% |
0 |
77.00% |
0 |
31 |
0 |
36 |
0 |
86.10% |
0 |
1 |
Yes |
PY4 |
DMPH |
Tri-City Medical Center |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Reported |
0.00% |
0 |
71.30% |
0 |
380 |
0 |
634 |
0 |
59.90% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
76 |
0 |
360 |
0 |
21.10% |
0 |
1 |
Yes |
PY4 |
DMPH |
Tri-City Medical Center |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
405 |
0 |
891 |
0 |
45.50% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Reported |
0.00% |
0 |
71.10% |
0 |
284 |
0 |
459 |
0 |
61.90% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Reported |
0.00% |
0 |
79.30% |
0 |
356 |
0 |
459 |
0 |
77.60% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
197 |
0 |
197 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Reported |
0.00% |
0 |
47.60% |
0 |
1159 |
0 |
1585 |
0 |
73.10% |
0 |
1 |
Yes |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Reported |
0.00% |
0 |
44.90% |
0 |
65 |
0 |
67 |
0 |
97.00% |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Reported |
0 |
0 |
1.07 |
0 |
7 |
0 |
5.857 |
0 |
1.1952 |
0 |
1 |
No |
PY4 |
DMPH |
Tri-City Medical Center |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
33 |
0 |
37.429 |
0 |
0.882 |
0 |
1 |
No |
PY4 |
DMPH |
Trinity Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
50 |
0 |
218 |
0 |
22.90% |
0 |
1 |
No |
PY4 |
DMPH |
Trinity Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
106 |
0 |
638 |
0 |
16.60% |
0 |
1 |
No |
PY4 |
DMPH |
Trinity Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Trinity Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
Reported |
0.00% |
0 |
48.10% |
0 |
132 |
0 |
204 |
0 |
64.70% |
0 |
1 |
Yes |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
Reported |
0.00% |
0 |
51.80% |
0 |
333 |
0 |
499 |
0 |
66.70% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
Reported |
0.00% |
0 |
39.40% |
0 |
556 |
0 |
1005 |
0 |
55.30% |
0 |
1 |
Yes |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
Reported |
0.00% |
0 |
31.90% |
0 |
12 |
0 |
40 |
0 |
30.00% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
Reported |
0.00% |
0 |
48.30% |
0 |
43 |
0 |
66 |
0 |
65.20% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
Reported |
0.00% |
0 |
27.40% |
0 |
424 |
0 |
894 |
0 |
47.40% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
Reported |
0.00% |
0 |
15.10% |
0 |
21 |
0 |
77 |
0 |
27.30% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
Reported |
0.00% |
0 |
30.90% |
0 |
13 |
0 |
48 |
0 |
27.10% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
Reported |
0.00% |
0 |
19.20% |
0 |
1622 |
0 |
3856 |
0 |
42.10% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC15 |
Q-WCC |
? BMI |
Reported |
0.00% |
0 |
69.20% |
0 |
523 |
0 |
586 |
0 |
89.30% |
0 |
1 |
NoS |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
Reported |
0.00% |
0 |
61.10% |
0 |
476 |
0 |
586 |
0 |
81.20% |
0 |
1 |
NoS |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
Reported |
0.00% |
0 |
55.80% |
0 |
472 |
0 |
586 |
0 |
80.60% |
0 |
1 |
NoS |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
Reported |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
N/A |
3 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
Reported |
0.00% |
0 |
66.40% |
0 |
21 |
0 |
31 |
0 |
67.70% |
0 |
1 |
NoS |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PC16 |
Q-W30 |
? First 15 Months |
Reported |
0.00% |
0 |
45.00% |
0 |
None |
1 |
None |
4 |
None |
1 |
1 |
NOs |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
Reported |
0.00% |
0 |
50.60% |
0 |
214 |
0 |
299 |
0 |
71.60% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
Reported |
0.00% |
0 |
71.40% |
0 |
81 |
0 |
85 |
0 |
95.30% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
Reported |
0.00% |
0 |
51.90% |
0 |
35 |
0 |
165 |
0 |
21.20% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
Reported |
0.00% |
0 |
45.00% |
0 |
91 |
0 |
165 |
0 |
55.20% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
Reported |
0.00% |
0 |
88.30% |
0 |
146 |
0 |
165 |
0 |
88.50% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
Reported |
0.00% |
0 |
24.80% |
0 |
None |
1 |
39 |
0 |
None |
1 |
1 |
Yes |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
Reported |
0.00% |
0 |
47.80% |
0 |
73 |
0 |
110 |
0 |
66.40% |
0 |
1 |
Yes |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
Reported |
0.00% |
0 |
99.20% |
0 |
147 |
0 |
147 |
0 |
100.00% |
0 |
1 |
No |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
Not Reported |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
Washington Hospital Healthcare District |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
Reported |
0.00% |
0 |
79.00% |
0 |
6 |
0 |
38.172 |
0 |
0.157 |
0 |
1 |
No |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CC2 |
Q-TRC |
Medication Reconciliation Post Discharge (MRP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CC4 |
Q-PCR |
Plan All-Cause Readmissions (PCR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-IHE1 |
Q-IHE1 |
Improving Health Equity 1 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-IHE1 |
Q-IHE1 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Black/African American |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-IHE1 |
Q-IHE1 |
? Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) - -Hispanic/Latino |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-IHE2 |
Q-IHE2 |
Improving Health Equity 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC1 |
Q-BCS |
Breast Cancer Screening (BCS) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC2 |
Q-CCS |
Cervical Cancer Screening (CCS) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC3 |
Q-WCV |
Child and Adolescent Well Care Visits |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC4 |
Q-CIS10 |
Childhood Immunization Status (CIS 10) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC5 |
Q-CHL |
Chlamydia Screening in Women (CHL) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC6 |
Q-CMS130 |
Colorectal Cancer Screening |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC7 |
Q-DEV |
Developmental Screening in the First Three Years of Life |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC8 |
Q-CMS349 |
HIV Screening Measure |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC9 |
Q-IMA |
Immunizations for Adolescents |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC10 |
Q-LSC |
Lead Screening in Children |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC11 |
Q-CMS69 |
Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC12 |
Q-CMS147 |
Preventive Care and Screening: Influenza Immunization |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC13 |
Q-CMS2 |
Preventive Care and Screening: Screening for Depression and Follow-Up Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC14 |
Q-CMS138 |
Preventative Care and Screening: Tobacco Use - Screening and Cessation Intervention |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 1 (informational only) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 2 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC14 |
Q-CMS138 |
? Rate 3 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC15 |
Q-WCC |
Weight Assessment & Counseling for Nutrition and Physical Activity for Children & Adolescents |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC15 |
Q-WCC |
? BMI |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC15 |
Q-WCC |
? Counseling for Nutrition |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC15 |
Q-WCC |
? Counseling for Physical Activity |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC16 |
Q-W30 |
Well-Child Visits in the First 30 Months of Life (W30) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC16 |
Q-W30 |
? 15 Months-30 Months |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PC16 |
Q-W30 |
? First 15 Months |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH1 |
Q-COB |
Concurrent Use of Opioids and Benzodiazepines (COB-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH2 |
Q-DRR |
Depression Remission or Response for Adolescents and Adults (DRR-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adults) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH2 |
Q-DRR |
? Follow-Up PHQ-9 (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH2 |
Q-DRR |
? Depression Remission (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH2 |
Q-DRR |
? Depression Response (Adolescents) - informational only |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH3 |
Q-FUA |
Follow-Up After Emergency Department Visit for Alcohol and Other Drug Abuse or Dependence |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH3 |
Q-FUA |
? 30 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH3 |
Q-FUA |
? 7 Days |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-BH4 |
Q-OHD |
Use of Opioids at High Dosage in Persons Without Cancer (OHD-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAC1 |
Q-CBP |
Controlling High Blood Pressure (CBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAC2 |
Q-QPP118 |
Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVSD < 40%) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAC3 |
Q-QPP6 |
Coronary Artery Disease (CAD): Antiplatelet Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAC4 |
Q-CMS135 |
Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAC5 |
Q-CMS347 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAD1 |
Q-CDC-H9 |
Comprehensive Diabetes Care: HbA1c Poor Control (>9.0%) (CDC-H9) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAD2 |
Q-CDC-E |
Comprehensive Diabetes Care: Eye Exam (CDC-E) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAD3 |
Q-CDC-N |
Comprehensive Diabetes Care: Medical Attention for Nephropathy (CDC-MN) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAH1 |
Q-HVL |
HIV Viral Suppression (HVL-AD) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAR1 |
Q-AMR |
Asthma Medication Ratio (AMR) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAR2 |
Q-PCE |
Pharmacotherapy Management of COPD Exacerbation (PCE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAR2 |
Q-PCE |
? Systemic Corticosteroid |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-CAR2 |
Q-PCE |
? Bronchodilator |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-OA1 |
Q-URI |
Appropriate Treatment for Upper Respiratory Infection (URI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-OA2 |
Q-AAB |
Avoidance of Antibiotic Treatment for Acute Bronchitis/Bronchiolitis (AAB) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-OA3 |
Q-QPP415 |
Emergency Medicine: Emergency Department Utilization of CT for Minor Blunt Head Trauma for Patients Aged 18 Years and Older |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-OA4 |
Q-LBP |
Use of Imaging Studies for Low Back Pain (LBP) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-MPH1 |
Q-PC02 |
Cesarean Birth (PC02-CH) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-MPH2 |
Q-CCW |
Contraceptive Care - All Women Ages 15-44 |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-MPH3 |
Q-PC05 |
Exclusive Breast Milk Feeding (PC-05) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-MPH4 |
Q-PPC-PST |
Prenatal and Postpartum Care: Postpartum Care (PPC-PST) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-MPH5 |
Q-PPC-PRE |
Prenatal and Postpartum Care: Timeliness of Prenatal Care (PPC-PRE) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-EC1 |
Q-QPP47 |
Advance Care Plan |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PS1 |
Q-STK-2 |
Discharged on Antithrombotic Therapy |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PS2 |
Q-QPP23 |
Perioperative Care: Venous Thromboembolism (VTE) Prophylaxis (When Indicated in ALL Patients) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PS3 |
Q-QPP76 |
Prevention of Central Venous Catheter (CVC)-Related Bloodstream Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PS5 |
Q-SSI |
Surgical Site Infection (SSI) |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
PY4 |
DMPH |
San Bernardino Mountains Community Hospital |
Q-PS6 |
Q-CDI |
Reduction in Hospital Acquired Clostridium Difficile Infections |
No Data Entered |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |
None |